Endo International plc (ENDP)
Symbol Info
Listed Symbol ENDP
Name Endo International plc
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $2,947,078,000
Latest Fiscal EPS $-4.61
Price Info
21 Day Moving Average $3.5641
21 Day EMA $3.510890
50 Day Moving Average $3.0934
50 Day EMA $3.466620
200 Day EMA $5.826540
200 Day Moving Average 6.179280
52 Week High $18.50
52 Week Low $1.97
52 Week Change $-77.946400
Alpha -0.037927
Beta 1.3119
Standard Deviation 0.190534
R2 0.055965
Periods 60
Share Information
10 Day Average Volume 7,248,854
20 Day Average Volume 7,082,566
30 Day Average Volume 9,550,501
50 Day Average Volume 8,693,559
Outstanding Shares 223,103,410
Float Shares 217,231,900
Percent Float 97.37%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 505
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 19,979,908
Institute Holdings Percent -
Institute Sold Previous 3 Months 44,537,232
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 6
Insider Holdings Percent 2.60%
Insider Sold Previous 3 Months 8
Insiders Shares Owned 5,871,510
Price Change
7 Day Price Change $-0.115
7 Day Percent Change -3.01%
21 Day Price Change $0.2249999
21 Day Percent Change 6.47%
30 Day Price Change $-0.3450003
30 Day Percent Change -8.52%
Month To Date Price Change $0.4950
Month To Date Percent 15.42%
90 Day Price Change $-0.255
90 Day Percent Change -6.44%
Quarter To Date $0.495000
Quarter To Date Percent 15.42%
180 Day Price Change $-4.195
180 Day Percent Change -53.10%
200 Day Price Change $-4.555
200 Day Percent Change -55.15%
Year To Date $-3.595
Year To Date Percent -49.25%
Profile
Description After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence in pain management. The acquisitions of Auxilium and Par increased the company's presence in urology and generics, respectively.
Details
Issue Type CS
Market Cap $826,598,134
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding 226,392,282
CEO Paul V. Campanelli
Employees 2,910
Last Audit UQ
Classification
CIK 0001593034
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address Simmonscourt Road, Ballsbridge
First Floor, Minerva House
Dublin, 4
Website http://www.endo.com
Facisimile
Telephone +353 12682000
Email
Key Ratios
Profitability
EBIT Margin 1.50
EBITDA Margin 24.0
Pre-Tax Profit Margin -51.1
Profit Margin Cont -17.05
Gross Margin 44.90
Profit Margin TOT -18.88
Income Statements
Revenue $2,206,527,000
Revenue Per Share $9.7465
Revenue 3 Years $-13.39
Revenue 5 Years $-0.53
Valuation Measures
PE Ratio -
Enterprise Value $7,748,170,225
Price To Sales 0.380137
Price To Free Cash 5.800000
PE High Last 5 Years -
Price To Book 2.6
Price To Cash Flow 5.7
PE Low Last 5 Years -
Price To Tangible Book -0.1
Financial Strength
Total Debt To Equity -
Int Coverage 0.1
Current Ratio 1.5
Leverage Ratio -14.3
Quick Ratio 1.1
Long Term Debt To Capital -
Assets
Receivables Turnover 1.8
Invoice Turnover 4.90
Assets Turnover 0.10
Management Effectiveness
Return Assets -5.63
Return On Equity 180.73
Return On Capital -
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
ENDP
Endo
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.